138 related articles for article (PubMed ID: 8383651)
1. Therapy of soft tissue infections with piperacillin/tazobactam.
Tassler H; Cullmann W; Elhardt D
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():105-12. PubMed ID: 8383651
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections.
Mouton Y; Leroy O; Beuscart C; Chidiac C; Senneville E; Ajana F; Lecocq P
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():87-95. PubMed ID: 8383658
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia.
Wise R
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():97-104. PubMed ID: 8383659
[TBL] [Abstract][Full Text] [Related]
4. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
Eklund AE; Nord CE
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
[TBL] [Abstract][Full Text] [Related]
5. Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center.
Siami FS; LaFleur BJ; Siami GA
Clin Ther; 2002 Jan; 24(1):59-72. PubMed ID: 11833836
[TBL] [Abstract][Full Text] [Related]
6. Safety profile of piperacillin/tazobactam in phase I and III clinical studies.
Kuye O; Teal J; DeVries VG; Morrow CA; Tally FP
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():113-24. PubMed ID: 8383652
[TBL] [Abstract][Full Text] [Related]
7. Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
Siami G; Christou N; Eiseman I; Tack KJ;
Antimicrob Agents Chemother; 2001 Feb; 45(2):525-31. PubMed ID: 11158750
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Wretlind B; Bergman L; Mentzing LO; Nyström PO; Kihlström E; Bäckstrand B; Skau T
Antimicrob Agents Chemother; 1992 Dec; 36(12):2766-73. PubMed ID: 1336347
[TBL] [Abstract][Full Text] [Related]
9. Piperacillin/tazobactam in complicated urinary tract infections.
Nowé P
Intensive Care Med; 1994 Jul; 20 Suppl 3():S39-42. PubMed ID: 7962988
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection.
Shlaes DM; Baughman R; Boylen CT; Chan JC; Charan NB; Cormier YC; Erickson A; Grossman R; Kirmani N; Suh B
J Antimicrob Chemother; 1994 Oct; 34(4):565-77. PubMed ID: 7868408
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
Shyr YM; Lui WY; Su CH; Wang LS; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Aug; 56(2):102-8. PubMed ID: 7553416
[TBL] [Abstract][Full Text] [Related]
12. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
File TM; Tan JS
Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
[TBL] [Abstract][Full Text] [Related]
14. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
[TBL] [Abstract][Full Text] [Related]
15. [Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
Shinagawa N; Yura J; Mashita K; Matsuno S; Rikiyama T; Hirayama T; Tanaka T; Otsuka K; Iwai S; Nakagawa Y
Jpn J Antibiot; 1995 Mar; 48(3):346-67. PubMed ID: 7752449
[TBL] [Abstract][Full Text] [Related]
16. [Multicentre clinical trial on efficacy and safety of domestic piperacillin/tazobactam for treatment of acute bacterial infections].
Liu Y; Wang R; Yu B
Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):41-4. PubMed ID: 11798851
[TBL] [Abstract][Full Text] [Related]
17. Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.
Xu ZR; Ran XW; Xian Y; Yan XD; Yuan GY; Mu SM; Shen JF; Zhang BS; Gan WJ; Wang J
J Antimicrob Chemother; 2016 Jun; 71(6):1688-96. PubMed ID: 26888908
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
Vestweber KH; Grundel E
Eur J Surg Suppl; 1994; (573):57-60. PubMed ID: 7524797
[TBL] [Abstract][Full Text] [Related]
19. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Niinikoski J; Havia T; Alhava E; Pääkkönen M; Miettinen P; Kivilaakso E; Haapiainen R; Matikainen M; Laitinen S
Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381
[TBL] [Abstract][Full Text] [Related]
20. Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital.
Marra F; Reynolds R; Stiver G; Bryce E; Sleigh K; Frighetto L; MacDougall C; Jewesson P
Diagn Microbiol Infect Dis; 1998 Jun; 31(2):355-68. PubMed ID: 9635910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
